600 patients66,869 observations120 daysLIVE

Patient P-01417

Synthetic patientNBL-101 · Day 100 · 35–44 · M · baseline S14Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Stable
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
89%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S14
  2. Day 48 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 57 GI-04 recommendedGI Support Protocol GI-04
  4. Day 58 Patient acceptedStarted GI-04 in the companion
  5. Day 64 ME-01 recommendedMonitoring Escalation ME-01
  6. Day 65 Patient acceptedStarted ME-01 in the companion
  7. Day 66 GI symptom burden −20% vs expectedGI Support Protocol GI-04
  8. Day 68 Deterioration detected before clinical escalationMonitoring Escalation ME-01
  9. Day 72 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 48.

Primary contributors, last 14 days
  • GI instability+10
  • Treatment adherence-3
  • Inflammatory activity+2
  • Nutritional resilience-2

What helped?

  • GI Support Protocol GI-04Day 57
    Result: symptom burden −20%
  • Monitoring Escalation ME-01Day 64
    Result: deterioration detected before clinical escalation
LIFE OS recommendation
Dietary Support Protocol NP-02
59%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 66% showed improvement
  • median effect visible after 10 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
59.8/100
stable · -0.3 vs previous 14 d
Toxicity
Blood
57.6/100
worsening · +5.1 vs previous 14 d
Sleep quality
Wearable
43.4/100
improving · +2.9 vs previous 14 d
Energy level
Daily log
3.4/10
stable · -0.0 vs previous 14 d
Stress level
Daily log
6.8/10
stable · +0.2 vs previous 14 d
Steps
Wearable
1,811
worsening · -90 vs previous 14 d
Adherence
Companion
41.8 %
worsening · -4.4 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards restoration · 42 from the failing basin, 58 from restoration.

Would help
  • NP-02 Dietary Support Protocol
    63% improved among 64 similar · onset 10 d · confidence 71%
  • SC-12 Supportive Compound
    76% improved among 51 similar · onset 6 d · confidence 71%
  • CR-01 Clinician Review
    100% improved among 8 similar · onset 5 d · confidence 71%
Would not help
  • Keep fibre low
    GI +2.6 next day on high-intake days · n 17
  • Keep fat low
    GI +2.4 next day on high-intake days · n 21
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Insoluble fibre
    +2.6detractor · 85%
  • Dietary fat load
    +2.4detractor · 88%
  • Alcohol
    +1.1no signal · 32%
  • Histamine load
    +0.8no signal · 19%
  • Simple carbohydrates
    +0.2no signal · 15%
  • Spicy / capsaicin
    -0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 80
    • MicrobiomeButyrate capacity 38/100
    • MicrobiomeF. prausnitzii depleted
    • Daily logFibre intake low in recent food logs
  • Inflammatory signalling 45
    • MicrobiomeBacteroides fragilis expansion
    • BloodInflammatory load index 61
  • Autonomic recovery 45
    • WearableResting HR 77 bpm
    • Wearable1,811 steps/day
  • Mucosal barrier integrity 20
    • Daily logGI symptom score 60 and rising
  • Drug metabolism and exposure 20
    • BloodToxicity index 58
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Rapid metabolizer
    Expected exposure
Microbiome
Shannon diversity 3.1 · butyrate capacity 38/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
53 ms
Sleep
6.9 h
Steps
2,093
Resting HR
76 bpm
Daily log: GI score 60, nutritional resilience 37, adherence 42.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0146554%S14NP-02improved56
P-0136047%S14GI-04improved52
P-0136847%S14GI-04improved53
P-0131146%S14ME-01improved49
P-0173246%S14ME-01improved45
P-0159545%S14GI-04no change51
P-0132844%S14SC-12no change49
P-0175144%S14ME-01improved48
P-0133943%S14GI-04improved54
P-0141043%S14GI-04no change52
P-0171642%S14GI-04improved56
P-0173342%S05SC-12no change49